Soma Y - Search Results

1

Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.

Ihn H, Fujimoto M, Sato S, Kikuchi K, Igarashi A, Soma Y, Takehara K. Ihn H, et al. Among authors: soma y. J Am Acad Dermatol. 1994 Oct;31(4):591-5. doi: 10.1016/s0190-9622(94)70221-7. J Am Acad Dermatol. 1994. PMID: 7916356

2

Anti-ribosomal P protein antibodies in a Japanese patient with systemic sclerosis.

Fujimoto M, Kawakami T, Takehara K, Soma Y. Fujimoto M, et al. Among authors: soma y. J Dermatol. 1996 Jan;23(1):33-6. doi: 10.1111/j.1346-8138.1996.tb03964.x. J Dermatol. 1996. PMID: 8720255

3

Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis.

Ihn H, Sato S, Fujimoto M, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K. Ihn H, et al. Among authors: soma y. Clin Exp Immunol. 1996 Sep;105(3):475-9. doi: 10.1046/j.1365-2249.1996.d01-774.x. Clin Exp Immunol. 1996. PMID: 8809137 Free PMC article.

4

Distribution of anti-p80-coilin autoantibody in collagen diseases and various skin diseases.

Fujimoto M, Kikuchi K, Tamaki T, Yazawa N, Kubo M, Ihn H, Sato S, Soma Y, Tamaki K. Fujimoto M, et al. Among authors: soma y. Br J Dermatol. 1997 Dec;137(6):916-20. Br J Dermatol. 1997. PMID: 9470907

5

Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines.

Soma Y, Fujimoto M. Soma Y, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 2):366-8. doi: 10.1016/s0190-9622(98)70586-9. J Am Acad Dermatol. 1998. PMID: 9486719 Review.

6

Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma.

Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: soma y. J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):64-9. doi: 10.1016/s0190-9622(00)90010-0. J Am Acad Dermatol. 2000. PMID: 10607321

7

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: soma y. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

8

Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yamane K, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Kubo M, et al. Among authors: soma y. Br J Dermatol. 2000 Aug;143(2):392-8. doi: 10.1046/j.1365-2133.2000.03668.x. Br J Dermatol. 2000. PMID: 10951151

9

Clinical evaluation of scleroderma spectrum disorders using a points system.

Ihn H, Sato S, Tamaki T, Soma Y, Tsuchida T, Ishibashi Y, Takehara K. Ihn H, et al. Among authors: soma y. Arch Dermatol Res. 1992;284(7):391-5. doi: 10.1007/BF00372068. Arch Dermatol Res. 1992. PMID: 1288419

10

Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon.

Takehara K, Soma Y, Ishibashi Y. Takehara K, et al. Among authors: soma y. Dermatologica. 1991;183(3):164-8. doi: 10.1159/000247662. Dermatologica. 1991. PMID: 1743381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters